| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/26/2012 | WO2012011045A1 Parapoxvirus vectors |
| 01/26/2012 | WO2012011034A2 Plants having enhanced yield-related traits and a method for making the same |
| 01/26/2012 | WO2012010768A1 Method for preparing an extract, and extract for treating cancer |
| 01/26/2012 | WO2012010711A1 Process |
| 01/26/2012 | WO2012010696A1 Methods for cancer management targeting co-029 |
| 01/26/2012 | WO2012010686A1 Invention relating to flocculation |
| 01/26/2012 | WO2012010674A1 Nkx2.2 inhibitors as drugs |
| 01/26/2012 | WO2012010321A1 Foetal haemoglobin inhibitor |
| 01/26/2012 | WO2012010280A1 Method for harvesting expression products |
| 01/26/2012 | WO2012010103A1 Aptamer, method of preparing same and use of same |
| 01/26/2012 | WO2012009977A1 FULLY HUMAN TNFα-FAB ANTIBODY AND PEGYLATED ANTIBODY THEREOF |
| 01/26/2012 | WO2012009963A1 Genetically engineered strain wsj-ia for producing isovaleryl spiramycin i. |
| 01/26/2012 | WO2012009953A1 Compositions and methods for controlled release of biomolecules |
| 01/26/2012 | WO2011153458A3 Compositions and methods for inhibition of or treatment of dengue virus infection |
| 01/26/2012 | WO2011139843A3 Multi-sirna compositions for reducing gene expression |
| 01/26/2012 | WO2011139842A3 Nucleic acid compounds for inhibiting fgfr3 gene expression and uses thereof |
| 01/26/2012 | WO2011118928A3 Pharmaceutical composition for preventing or treating heart failure and method for screening agent for preventing or treating heart failure |
| 01/26/2012 | WO2011115458A3 Dual antagonist for tnf-α and il-21 for preventing and treating autoimmune diseases |
| 01/26/2012 | WO2011115456A3 Tnf-α and tweak dual antagonist for the prophylaxis and treatment of autoimmune diseases |
| 01/26/2012 | WO2011105841A9 Recombinant expression vector for expressing brazzein, and novel multiple mutation brazzein variant having greater sweetness |
| 01/26/2012 | WO2011100982A3 SUPPRESSORS OF RNA SILENCING AS MODULATORS OF miRNA LEVELS |
| 01/26/2012 | WO2011081928A3 Compositions and methods for altering cocaine esterase activity |
| 01/26/2012 | WO2011053898A3 Plants and seeds with altered storage compound levels, related constructs and methods involving genes encoding proteins with similarity to bacterial 2,4-dihydroxy-hept-2-ene-1,7-dioic acid class ii-like aldolase proteins |
| 01/26/2012 | WO2011003557A8 A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 01/26/2012 | WO2010124324A9 Manipulating fructan biosynthesis and enhancing plant biomass |
| 01/26/2012 | WO2010009404A8 Markers associated with soybean rust resistance and methods of use therefor |
| 01/26/2012 | US20120023627 Plant gene regulatory elements |
| 01/26/2012 | US20120023626 Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same |
| 01/26/2012 | US20120023624 Means and methods for mediating protein interference |
| 01/26/2012 | US20120023622 Drought tolerant plants and related constructs and methods involving genes encoding ferredoxin family proteins |
| 01/26/2012 | US20120023620 Production of functionalized linear dna cassette and quantum dot/nanoparticle mediated delivery in plants |
| 01/26/2012 | US20120023619 Linear dna molecule delivery using pegylated quantum dots for stable trasformation in plants |
| 01/26/2012 | US20120023618 Methods and materials for conferring resistance to pests and pathogens of plants |
| 01/26/2012 | US20120023617 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding snf2 domain-containing polypeptides |
| 01/26/2012 | US20120023616 Methods for preventing or inhibiting microbial infection of plants and plant exhibiting resistance to microbial infection |
| 01/26/2012 | US20120023615 Transplastomic plants free of the selectable marker |
| 01/26/2012 | US20120023614 Environmental stress-inducible 557 promoter isolated from rice and uses thereof |
| 01/26/2012 | US20120023611 Isolated Novel Nucleic Acid and Protein Molecules from Corn and Methods of Using Thereof |
| 01/26/2012 | US20120023610 Soybean variety a1024227 |
| 01/26/2012 | US20120023609 Soybean variety a1023673 |
| 01/26/2012 | US20120023608 Soybean variety a1023667 |
| 01/26/2012 | US20120023607 Soybean variety a1023585 |
| 01/26/2012 | US20120023606 Soybean variety a1023535 |
| 01/26/2012 | US20120023605 Altering root structure during plant development |
| 01/26/2012 | US20120023604 Hybrid cultivars of poa bulbosa |
| 01/26/2012 | US20120022236 Recombinant Anti-VLA4 Antibody Molecules |
| 01/26/2012 | US20120022235 Promoter molecules for use in plants |
| 01/26/2012 | US20120022145 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof |
| 01/26/2012 | US20120022144 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof |
| 01/26/2012 | US20120022141 Compositions and methods for inhibiting expression of a gene from the jc virus |
| 01/26/2012 | US20120022139 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration |
| 01/26/2012 | US20120022138 Means for inhibiting the expression of ang2 |
| 01/26/2012 | US20120022134 METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA |
| 01/26/2012 | US20120022133 Antisense modulation of cholesteryl ester transfer protein expression |
| 01/26/2012 | US20120022132 Compositions and methods for inhibiting expression of mutant egfr gene |
| 01/26/2012 | US20120022131 Breast cancer related gene rqcd1 |
| 01/26/2012 | US20120022128 PKIB and NAALADL2 for Target Genes of Prostate Cancer Therapy and Diagnosis |
| 01/26/2012 | US20120022005 Synthetic Dragline Spider Silk-Like Proteins |
| 01/26/2012 | US20120021994 Novel cancer antigen eef2 |
| 01/26/2012 | US20120021985 Albumin fusion proteins |
| 01/26/2012 | US20120021984 Glycoprotein Hormone Analogs |
| 01/26/2012 | US20120021975 Antibiotic peptides |
| 01/26/2012 | US20120021953 Rapid Subcloning Using Site-Specific Recombination |
| 01/26/2012 | US20120021952 Focused libraries of genetic packages |
| 01/26/2012 | US20120021950 Expression Vector |
| 01/26/2012 | US20120021922 Translation-coupling systems |
| 01/26/2012 | US20120021522 Method for the Evolutionary Design of Biochemical Reaction Networks |
| 01/26/2012 | US20120021521 Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity |
| 01/26/2012 | US20120021520 Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity |
| 01/26/2012 | US20120021516 NOVEL STRUCTURALLY DESIGNED shRNAs |
| 01/26/2012 | US20120021506 Regulatory sequences for expressing gene products in plant reproductive tissue |
| 01/26/2012 | US20120021491 Identification of antigen or ligand-specific binding proteins |
| 01/26/2012 | US20120021490 Glucanases, nucleic acids encoding them and methods for making and using them |
| 01/26/2012 | US20120021488 Thermotolerant non-k12 escherichia coli phytase and its production |
| 01/26/2012 | US20120021485 Hybrid alpha-amylases |
| 01/26/2012 | US20120021475 Method for producing (+)-zizaene |
| 01/26/2012 | US20120021472 Method for the Production of Glutaconate |
| 01/26/2012 | US20120021470 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 01/26/2012 | US20120021469 Amidases and methods of their use |
| 01/26/2012 | US20120021464 Thermostable reverse transcriptases and uses thereof |
| 01/26/2012 | US20120021463 Method and apparatus for amplification of nucleic acid sequences by using thermal convection |
| 01/26/2012 | US20120021462 Recombinase polymerase amplification |
| 01/26/2012 | US20120021458 Thermotolerant transglutaminase originating in actinomyces |
| 01/26/2012 | US20120021450 Methods for magnetic resonance imaging |
| 01/26/2012 | US20120021440 Methods for testing ligand binding to g protein-coupled receptors |
| 01/26/2012 | US20120021425 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 01/26/2012 | US20120021424 Device and Method for Thermal Cycling |
| 01/26/2012 | US20120021418 Gene that imparts oxygen resistance and application thereof |
| 01/26/2012 | US20120021405 Single Chain Antibody for the Detection of Noroviruses |
| 01/26/2012 | US20120021403 Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof |
| 01/26/2012 | US20120021092 Polypeptides with xylanase activity |
| 01/26/2012 | US20120021043 Nucleic Acids Comprising formula (NuGlXmGnNv)a and Derivatives Thereof as Immunostimulating Agent/Adjuvant |
| 01/26/2012 | US20120021039 Expression of neuropeptides in mammalian cells |
| 01/26/2012 | US20120021035 Nanoparticles containing plymeric nucleic acid homologs, pharmaceutical composition and articles of manufacture containing same and methods of use thereof |
| 01/26/2012 | US20120021004 Medium and method of deriving and using a mutated bacteria strain |
| 01/26/2012 | US20120020997 Multi plasmid system for the production of influenza virus |
| 01/26/2012 | US20120020990 Isolated mammalian monocyte cell genes; related reagents |
| 01/26/2012 | US20120020988 Antibodies specifically binding to human TSLPR and methods of use |
| 01/26/2012 | US20120020985 Antibodies against il-17br |
| 01/26/2012 | US20120020980 High affinity human antibodies to human cytomegalovirus (cmv) gb protein |